MYELOPEROXIDASE OXIDATION OF METHIONINE ASSOCIATES WITH EARLY CYSTIC FIBROSIS LUNG DISEASE

RATIONALE: Cystic fibrosis (CF) lung disease progressively worsens from infancy to adulthood. Disease-driven changes in early CF airway fluid metabolites may identify therapeutic targets to curb progression. METHODS: CF patients aged 12–38 months (n=24; 3/24 later denoted as CF screen positive, inco...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur Respir J
Päätekijät: Chandler, Joshua D., Margaroli, Camilla, Horati, Hamed, Kilgore, Matthew B., Veltman, Mieke, Liu, H. Ken, Taurone, Alexander J., Peng, Limin, Guglani, Lokesh, Uppal, Karan, Go, Young-Mi, Tiddens, Harm A.W.M., Scholte, Bob J., Tirouvanziam, Rabindra, Jones, Dean P., Janssens, Hettie M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7034951/
https://ncbi.nlm.nih.gov/pubmed/30190273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.01118-2018
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia